Novel biomarker platform for a 3Rs approach to assessment of developmental and reproductive toxicity Principal Investigator: Dr Catherine Pears, University of Oxford Project grant
Imprecision and importance: Probabilistic graphical models in toxicology Principal Investigator: Dr Jonathan Pitchford, University of York Strategic grant
Uncertainty and confidence in applying mathematical models and in vitro data in toxicological safety assessments Principal Investigator: Dr John Gosling, University of Leeds Strategic grant
Structural identifiability and indistinguishability analysis as tools for quantitative and systems pharmacology to support the 3Rs Principal Investigator: Dr Michael Chappell, University of Warwick Strategic grant
Human pluripotent stem cell cardiomyocytes and hepatocytes with engineered genotypes for drug safety evaluation Principal Investigator: Professor Chris Denning, University of Nottingham Project grant
Prediction of human cardiotoxic QT prolongation using in vitro multiple ion channel data and mathematical models of cardiac myocytes Principal Investigator: Dr Gary Mirams, University of Oxford Strategic grant
Combinatorial mathematical modelling & novel toxicological profiling of drug-induced hepatotoxicity Principal Investigator: Dr John Ward, Loughborough University PhD Studentship
Refining, reducing and replacing in vivo WHO-standard preclinical assays of snake venom pathology and antivenom efficacy Principal Investigator: Dr Robert Harrison, Liverpool School of Tropical Medicine PhD Studentship
Developing an integrated "in vitro carcinogenicity predictive tool" utilising in vitro cell signalling and cell behaviour assessment coupled with in vitro genotoxicity data Principal Investigator: Professor Gareth Jenkins, Swansea University Strategic grant
Development of human epithelial cell transformation models for carcinogen screening, employing defined phenotypic endpoints mechanistically representative of rate-limiting events in human carcinogenesis Principal Investigator: Professor Robert Newbold, Brunel University Strategic grant
Pilot study investigating the use human stem cell derived neurons in toxicity testing Principal Investigator: Dr Eric Hill, Aston University Pilot study grant
FIGCS: An in vitro model to replace ecotoxicity testing of fish to pharmaceuticals Principal Investigator: Professor Christer Hogstrand, King's College London Project grant
Development of cell based assays as replacement assays for Botulinum toxins and antitoxins Principal Investigator: Dr Dorothea Sesardic, National Institute for Biological Standards and Control Project grant
Stem cell-derived cardiomyocytes for detection of cardiotoxicity in cancer therapeutics Principal Investigator: Professor Sian Harding, Imperial College London Project grant
A 3D tissue model of breast morphogenesis for replacing animals in testing for endocrine disrupting substances Principal Investigator: Professor Charles Vyvyan Howard, University of Ulster Project grant
The validation of defined genotoxic thresholds, leading to better in vitro risk assessments of carcinogenic potential Principal Investigator: Professor Gareth Jenkins, Swansea University PhD Studentship
The snail assay as an alternative to the rodent Hershberger assay for detecting androgens and anti-androgens Principal Investigator: Dr Susan Jobling, Brunel University Project grant
Development and validation of mechanisms-based in vitro transformation assays for carcinogen screening Principal Investigator: Professor Robert Newbold, Brunel University Project grant
Development of a mechanistically informative genome-wide, replacement chemicals screening technology Principal Investigator: Professor Andrew Cossins, University of Liverpool Project grant
Metabolically competent stem cell systems: novel means to implement 3Rs in better drug safety assessment Principal Investigator: Professor Roland Wolf, University of Dundee Project grant